Home/Filings/4/0001003642-16-000030
4//SEC Filing

IMPAX LABORATORIES INC 4

Accession 0001003642-16-000030

CIK 0001003642operating

Filed

Aug 30, 8:00 PM ET

Accepted

Aug 31, 2:49 PM ET

Size

7.2 KB

Accession

0001003642-16-000030

Insider Transaction Report

Form 4
Period: 2016-08-30
Boothe Douglas
President, Generics Division
Transactions
  • Award

    Stock Option (Right to Buy)

    2016-08-30+50,50050,500 total
    Exercise: $24.42Exp: 2026-08-30Common Stock (50,500 underlying)
  • Award

    Common Stock

    2016-08-30+62,60062,600 total
Footnotes (1)
  • [F1]The option vests in four equal annual installments beginning on August 1, 2017, which is the first anniversary of the effective date of Mr. Boothe's appointment as the Company's President, Generics Division.

Issuer

IMPAX LABORATORIES INC

CIK 0001003642

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001003642

Filing Metadata

Form type
4
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 2:49 PM ET
Size
7.2 KB